Found this article while looking around late tonight.. Mentions the clinical trial comparing Orthocell’s tendon regeneration therapy to corticosteroids is on track for recruitment completion by the second quarter of CY2019 as well as OCC revenue having increased 80% in the last 9 months for the corresponding previous 9 months.
https://kalkinemedia.com/news/orthocells-shares-rose-on-asx-post-application-to-tga-for-approval-of-celgro/
Found this article while looking around late tonight.. Mentions...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.015(3.85%) |
Mkt cap ! $78.49M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.0¢ | $67.49K | 179.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 26290 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 94 | 1 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |